DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 54,100 shares, an increase of 14.6% from the December 15th total of 47,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 541.0 days.
Analyst Ratings Changes
Separately, UBS Group lowered shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
View Our Latest Stock Analysis on DiaSorin
DiaSorin Price Performance
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Articles
- Five stocks we like better than DiaSorin
- What is a Low P/E Ratio and What Does it Tell Investors?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- There Are Different Types of Stock To Invest In
- Oilfield Leader SLB: An AI Name You Need to Know
- 3 Warren Buffett Stocks to Buy Now
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.